Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China flag China · Delayed Price · Currency is CNY
5.87
-0.01 (-0.17%)
Apr 29, 2026, 3:00 PM CST
-2.98%
Market Cap 3.00B
Revenue (ttm) 1.95B
Net Income (ttm) 38.24M
Shares Out 534.07M
EPS (ttm) 0.07
PE Ratio 84.00
Forward PE n/a
Dividend 0.15 (2.59%)
Ex-Dividend Date Jun 5, 2025
Volume 11,811,600
Average Volume 23,049,362
Open 5.85
Previous Close 5.88
Day's Range 5.78 - 5.93
52-Week Range 5.37 - 7.53
Beta 0.64
RSI 43.11
Earnings Date Apr 29, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Sector Healthcare
Founded 1990
Employees 1,266
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600613
Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements

News

There is no news available yet.